ResultsIQ

ResultsIQ › Latest results › Acutaas Chemicals Limited

Acutaas Chemicals Limited Q2 FY27 results press release summary

NSE: ACUTAAS · BSE: 543349

Results press release of 27 Oct 2026, summarised by AI from the filing.

Acutaas Chemicals Q2 FY27 revenue ₹4,369 mn, up 42.7% YoY, and PAT ₹1,231 mn, up 71.4% YoY; FY27 revenue growth guidance raised to around 30%.

Key takeaways

  1. Q2 revenue Revenue from operations ₹4,369 mn, up 42.7% YoY, with PAT ₹1,231 mn, up 71.4% YoY, and PAT margin 28.2%.
  2. FY27 guidance Revenue growth guidance raised from 25% to around 30% and EBITDA margin guidance raised to 38-40%.
  3. South Korea plant South Korea manufacturing facility was inaugurated ahead of schedule, adding semiconductor chemical capacity.
  4. Growth driver Continued momentum in the Pharmaceutical Intermediates business drove the quarter's performance.
  5. Main risk Softer performance in the Specialty Chemicals segment offset the pharma intermediates momentum.

Original filing on BSE

Acutaas Chemicals Limited Q1 FY27 results

As filed: Revenue ₹330 cr (+59% year on year), EBITDA ₹113 cr (+122% year on year), PAT ₹75.0 cr (+70% year on year), EBITDA margin 34.3% (+966 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹422 cr, EBITDA ₹181 cr, PAT ₹137 cr, EBITDA margin 43.0%. Not scored. No result for the same quarter last year. Share price after the results: +25.2% in 29 days (Nifty 500: −0.9%).
  • Q3 FY26: Revenue ₹391 cr, EBITDA ₹154 cr, PAT ₹112 cr, EBITDA margin 39.5%. Not scored. No result for the same quarter last year. Share price after the results: +30.9% in 30 days (Nifty 500: +1.5%).
  • Q2 FY26: Revenue ₹305 cr, EBITDA ₹97.0 cr, PAT ₹73.0 cr, EBITDA margin 31.8%. Not scored. No result for the same quarter last year. Share price after the results: +10.2% in 28 days (Nifty 500: +1.2%).
  • Q1 FY26: Revenue ₹206 cr, EBITDA ₹51.0 cr, PAT ₹45.0 cr, EBITDA margin 24.8%. Not scored. No result for the same quarter last year. Share price after the results: +20.5% in 30 days (Nifty 500: −2.4%).

Past price moves after results do not indicate future moves. Not a recommendation.

Acutaas Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.